TFA Therapeutics RAJAF Cash Flow Statement (2020-2023)

OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

TFA Therapeutics Quarterly Cash Flow Statement

Periods 3 quarters
Latest Dec 2023

TFA Therapeutics reported cash from operations of -$1.23M and free cash flow of -$2.45M for the quarter ended Dec 2023. This cash flow statement covers 3 quarters of results from Dec 2020 through Dec 2023, standardized by Business Quant from the company’s SEC filings.

TFA Therapeutics Cash Flow Statement API

Pull TFA Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RAJAF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY